Statements (125)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:affiliated_with |
Aduro Biotech Inc.
|
| gptkbp:appears_in |
European market
|
| gptkbp:collaborated_with |
academic institutions
|
| gptkbp:collaborates_with |
various research institutions
|
| gptkbp:collaborations |
research organizations
|
| gptkbp:develops |
cancer treatments
|
| gptkbp:employs |
gptkb:physicist
|
| gptkbp:focuses_on |
gptkb:vaccine
immune response patient care innovative solutions cancer research therapeutic solutions cancer therapies biological therapies cancer treatment advancements patient treatment patient-centric solutions therapeutic advancements cancer immunotherapy research cancer immunotherapy advancements patient-centered therapies therapeutic advancements in cancer therapeutic research advancements |
| gptkbp:founded |
gptkb:2014
|
| gptkbp:has_goal |
improve patient outcomes
|
| gptkbp:has_mission |
advance cancer treatment
|
| gptkbp:has_part |
gptkb:scientific_collaborations
clinical trials partnerships patents scientific publications research programs research and development team research and development projects research collaborations clinical research initiatives clinical research projects clinical partnerships clinical trials network clinical research collaborations clinical development programs clinical trials program clinical research initiatives network |
| gptkbp:headquarters |
gptkb:Ireland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aduro Biotech Ireland
|
| gptkbp:is_active_in |
research and development
therapeutic areas healthcare innovation biomedical research initiatives cancer immunotherapy biomedical innovation healthcare research initiatives drug development initiatives |
| gptkbp:is_engaged_in |
clinical trials
biotech innovation healthcare solutions healthcare advancements scientific innovation clinical innovation biotech research initiatives biotech solutions |
| gptkbp:is_involved_in |
drug development
drug discovery healthcare research biomedical research clinical studies scientific studies therapeutic development clinical research studies scientific research projects patient care research therapeutic research clinical research advancements patient research biotech research therapeutic development projects |
| gptkbp:is_known_for |
gptkb:Research_Institute
collaborative research efforts scientific innovation cutting-edge research innovative therapies scientific breakthroughs innovative cancer treatments patient-focused research therapeutic breakthroughs |
| gptkbp:is_part_of |
international research collaborations
global research community biotech ecosystem biomedical community global healthcare initiatives biotech initiatives global biotech community international biotech community |
| gptkbp:is_recognized_for |
research excellence
scientific contributions innovation in treatment therapeutic research therapeutic innovation clinical advancements clinical research excellence |
| gptkbp:is_supported_by |
government grants
research funding research institutions biomedical research funding biotech funding biotech research funding biotech investors biomedical funding biotech grants |
| gptkbp:key_people |
Stephen A. Williams
|
| gptkbp:located_in |
gptkb:Dublin
|
| gptkbp:operates_in |
biopharmaceutical sector
|
| gptkbp:part_of |
Aduro Biotech Inc.
|
| gptkbp:participates_in |
clinical research
|
| gptkbp:partnerships |
pharmaceutical companies
|
| gptkbp:products |
gptkb:ADU-S100
ADU-CLD |
| gptkbp:receives_funding_from |
gptkb:Company
|
| gptkbp:research_focus |
novel therapies
|
| gptkbp:targets |
solid tumors
|
| gptkbp:uses |
STING pathway
|